Deferoxamine mesylate (Ba 33112)

For research use only.

Catalog No.S5742 Synonyms: Desferrioxamine B, DFOM, NSC 644468

19 publications

Deferoxamine mesylate (Ba 33112) Chemical Structure

CAS No. 138-14-7

Deferoxamine mesylate (Ba 33112, Desferrioxamine B, DFOM, NSC 644468) is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy.

Selleck's Deferoxamine mesylate (Ba 33112) has been cited by 19 publications

Purity & Quality Control

Choose Selective Ferroptosis Inhibitors

Biological Activity

Description Deferoxamine mesylate (Ba 33112, Desferrioxamine B, DFOM, NSC 644468) is the mesylate salt of Deferoxamine, which forms iron complexes and is used as a chelating agent. Deferoxamine is a ferroptosis inhibitor that stabilizes HIF-1α expression and improves HIF-1α transactivity in hypoxic and hyperglycemic states in vitro. Deferoxamine decreases beta-amyloid (Aβ) deposition and induces autophagy.
Targets
HIF-1α [1]
()
Beta Amyloid [1]
()
Ferroptosis [2]
()
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SK-N-MC MXHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MWq3NkBpenN? NWr0OFNlSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1PNU2FIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA1NjVzIN88UU4> M3XtXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5NkCyOlA{Lz5zN{[wNlYxOzxxYU6=
SK-N-MC MXHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MnHoO|IhcHK| NGLNR|VCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW4uVUNiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFUh|ryPLh?= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTZyMUW3O{c,OTl4MEG1O|c9N2F-
SK-N-MC NHKzSo1CdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M2f4UlczKGi{cx?= M17KO2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1utUk1OSyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gO{4{PSEQvF2u M1jmbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MkG2OVYzLz5zOUKxOlU3OjxxYU6=
A549 Mmn0RY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M2HLNlczKGi{cx?= NWKw[GJrSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[XRiaIXtZY4hSTV2OTDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hPy53IN88UU4> MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh4MUS5PUc,OjJ6NkG0PVk9N2F-
SK-N-MC MnnMRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M2XsfFk3KGi{cx?= NWqzTFk3SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1PNU2FIHPlcIx{KGGodHXyJFk3KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA5NjV6IN88UU4> NVLW[W1XRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUewOlQxPjlpPkG3NFY1ODZ7PD;hQi=>
MDCK MWnUc5hq[2m2eTDhd5NigQ>? MorPWI95cWOrdImgbY4hVUSFSzDj[YxteyCkeTDNWHQhdWW2aH;kMEBKSzVyIE2gPU41QSEQvF2u MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODB2MU[3Nkc,OjByNEG2O|I9N2F-
SK-N-MC MUnDfZRwfG:6aXPpeJkh[XO|YYm= M{TTRlczKGi{cx?= MVHDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT{1PNU2FIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA6Njh7IN88UU4> MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODNyM{e2PEc,OjB|MEO3Olg9N2F-
SK-N-MC Ml\hRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M4TjUlczKGi{cx?= M4G4R2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF1KGi3bXHuJHNMNU5vTVOgZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDFyIN88UU4> MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh4MUS5PUc,OjJ6NkG0PVk9N2F-
DMS53 MXnBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NUS1ZXJlPzJiaILz M2jNWWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIF1KGi3bXHuJGROWzV|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyOCEQvF2u MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh4MUS5PUc,OjJ6NkG0PVk9N2F-
SK-MN-C MmrZRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MnzPRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCVSz3NUk1EKGOnbHzzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDF{LkC1JO69VS5? NYLVZpJjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUixOVk6OjJpPkG4NVU6QTJ{PD;hQi=>
SK-N-MC MoTQRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MWG3NkBpenN? NUjye|hYSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT{1PNU2FIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyOi53IN88UU4> M4\rOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OEW4NVAyLz5{Mki1PFExOTxxYU6=
SK-N-MC NVjrUYxkSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MXHBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONLV6tUWMh[2WubIOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOTRwMkKg{txONg>? NFnkTpI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{m2N|M4Oid-MUe5OlM{PzJ:L3G+
SK-N-MC MljHWI95cWOrdImgZZN{[Xl? MmjkWI95cWOrdImgbY4hcHWvYX6gV2suVi2PQzDj[YxteyCkeTDNWHQhdWW2aH;kMEBKSzVyIE2gNVYvODRizszNMi=> M3zqd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMESxOlczLz5{MEC0NVY4OjxxYU6=
SK-N-MC NFPRO4FCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= Ml;qO|IhcHK| MVTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONLV6tUWMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEG2MlgyKM7:TT6= MkO5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh6NEG1NVQoRjJ6OESxOVE1RC:jPh?=
SK-N-MC MWfBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M4jIclczKGi{cx?= MWLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONLV6tUWMh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEG3MlA4KM7:TT6= NGm0V5E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC1OVk2OCd-MkGwOVU6PTB:L3G+
SK-N-MC NYriO2U6SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MkPOO|IhcHK| M33zRWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1utUk1OSyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNVcvODdizszNMi=> MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF5MkOxNUc,OjJzN{KzNVE9N2F-
U2OS M2n6VGZ2dmO2aX;uJIF{e2G7 M4Ljc|MxKG2rboO= Ml;wRYN1cX[jdHnvckBw\iCqdX3hckBJUUZzYXzwbIEh\XiycnXzd4VlKGmwIFTGXE1qdmS3Y3XkJIh2dWGwIGWyU3Mh[2WubIOgbY5kfWKjdHXkJIZweiB|MDDtbY5{KHC{aX;yJJRwKESIWD3pcoR2[3Srb36gcYVie3W{ZXSgZYZ1\XJib4\ldo5q\2i2IHnuZ5Vj[XSrb36gZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxKD1iMUeuPEDPxE1w NYPXS20{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxO|I4ODRpPkKyNVczPzB2PD;hQi=>
HL60 M3jFeGN6fG:2b4jpZ4l1gSCjc4PhfS=> NWmye2pQS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUEx4MDDj[YxteyCkeTDhcIFu[XJiYnz1[UBie3OjeTygS2k2OCB;IEG4MlQh|ryPLh?= NYDMflBNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyOlYyQDVpPkKzNlY3OTh3PD;hQi=>
SK-N-MC NV7yUnVrSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NGPRV3g4OiCqcoO= NI\INJVCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW4uVUNiY3XscJMhdWWjc4Xy[YQh[W[2ZYKgO|IhcHK|IHH0JFM4KGSnZ1OgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hOjFwNkOg{txONg>? MlzYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|MUK5OFgoRjJ|M{GyPVQ5RC:jPh?=
SK-N-MC M1XHWWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MXzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKFONLV6tUWMh[2WubIOsJGlEPTBiPTCyNkDPxE1w M4DtblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7NkCxOVc4Lz5zOU[wNVU4PzxxYU6=
SK-N-MC NWX1NGFKSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NG\VcmU4OiCqcoO= NH3yXXNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW4uVUNiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VWyCjc4PhfUwhUUN3MDC9JFIzNjdizszNMi=> MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTh2NkGxPEc,OjF6NE[xNVg9N2F-
SK-N-MC NHHNb3lEgXSxdH;4bYNqfHliYYPzZZk> NI[xT|A4OiCqcoO= MmfCR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2suVi2PQzDj[YxteyCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB5MjDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMkKuO{DPxE1w NFjuR|A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{K3OlIxQSd-MkOyO|YzODl:L3G+
K562 M{T6RmN6fG:2b4jpZ4l1gSCjc4PhfS=> M{XB[GN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGs2PjJiY3XscJMtKEeLNUCgQUA{Oy5zIN88UU4> M13QTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|Mk[2NVg2Lz5{M{K2OlE5PTxxYU6=
HT29 NV7P[|R3S3m2b4TvfIlkcXS7IHHzd4F6 NHS1[GI4OiCqcoO= MkDUR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTHQzQSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRUKGG|c3H5MEBKSzVyIE2gN|YvOSEQvF2u MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDN2NU[xNEc,OTh|NEW2NVA9N2F-
HT-29 M4DPPWNmdGxiY4njcIUh[XO|YYm= Mmr3NVAhfU1? NVLIc2lkOjRiaILz M3W1OmNmdGxiY4njcIUh[XK{ZYP0JIlvKG6xY3;kZZpwdGVicILleJJm[XSnZDDoeY1idiCKVD2yPUBk\WyuczDhd5Nme3OnZDDhd{Bi[2O3bYXsZZRqd25iYYSgUUBxcGG|ZTDheEAyOCC3TTDh[pRmeiB{NDDodpM> MmnxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjB|NUOxOVIoRjJyM{WzNVUzRC:jPh?=
HT-29 NXXMSZlvS2WubDDjfYNt\SCjc4PhfS=> M324W|UhfU1? M4PJTlI1KGi{cx?= M{XyeWNmdGxiY4njcIUh[XK{ZYP0JIlvKG6xY3;kZZpwdGVicILleJJm[XSnZDDoeY1idiCKVD2yPUBk\WyuczDhd5Nme3OnZDDhd{Bi[2O3bYXsZZRqd25iYYSgUUBxcGG|ZTDheEA2KHWPIHHmeIVzKDJ2IHjydy=> M2C3PVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{WzNVUzLz5{MEO1N|E2OjxxYU6=
HCT116 M{\yNmZ2dmO2aX;uJIF{e2G7 MX[yOEBpenN? NXXOZW8xWGixdH;jfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh\XiycnXzd4lv\yC5aXzkJJR6eGVicEWzJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KG[xbHzve4VlKGK7IHzp[4h1KGm{cnHkbYF1cW:wIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{BjgSCPVGOgZZN{[XliaX6gdJJme2WwY3Wgc4YhSUyDIHHu[EBH\UOuMx?= M3LSeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwPFM4Lz5{NEmwNFg{PzxxYU6=
HeLa M1XT[GJi[3Sncnnvd5RifGmlIHHzd4F6 MmfhQlExOCC3TR?= MnPFNUBpeg>? M4PremJi[3Sncnnvd5RifGmlIHHjeIl3cXS7IHHnZYlve3RiQ3jsZY16\GmjIITyZYNpd22jdHnzJJNmem:4YYKgUFIhcW6oZXP0[YQhcW5iaIXtZY4hUGWOYTDj[YxteyCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDjc41xd3WwZDD0doVifGWmIHH0JF4yODBidV2g[o9zKDFiaIKgdJJqd3JiaX7m[YN1cW:wIH3lZZN2emWmIEK0JIhzeyCyb4P0JIlv\mWldHnvckBjgSCvaXPyc5Nkd3C7 NYfMUoc6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwNlc6OzdpPkK1NFI4QTN5PD;hQi=>
SK-N-BE(2)-M17 M2e3eGN6fG:ycn;0[YN1cW:wIHHzd4F6 M4flOFEhdU1? MofzNkBpenN? MV7DfZRweHKxdHXjeIlwdiCjZ3HpcpN1KFCTLXnu[JVk\WRiY3XscEBl\WG2aDDpckBpfW2jbjDTT{1PNUKHKEKpMW0yPyClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDj[YxtKH[rYXLpcIl1gSCjdDCxJI1OKHC{ZYTy[YF1\WRiZn;yJFIhcHK|IH\vcIxwf2WmIHL5JFEhdU1iUGGgZYRlcXSrb36gcYVie3W{ZXSgZYZ1\XJiMkSgbJJ{KGK7IFzETEBie3OjeR?= MlPzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{OEW5NVUoRjJ6Mki1PVE2RC:jPh?=
SK-N-BE(2)-M17 M3rCRmN6fG:ycn;0[YN1cW:wIHHzd4F6 NYHKOnh3OSCvTR?= NVjud2RDOiCqcoO= NILhVVdEgXSxcILveIVkfGmxbjDh[4FqdnO2IFiyU|IucW6mdXPl[EBk\WyuIHTlZZRpKGmwIHj1cYFvKFONLV6tRmUpOilvTUG3JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGOnbHygeoli[mmuaYT5JIF1KDFibV2gdJJmfHKnYYTl[EBnd3JiMjDodpMh\m:ubH;3[YQh[nliMTDtUUBJOk9{IHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDJ2IHjyd{BjgSCORFigZZN{[Xl? Mm[4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh{OEW5NVUoRjJ6Mki1PVE2RC:jPh?=
SK-N-BE(2)-M17 MWLDfZRweHKxdHXjeIlwdiCjc4PhfS=> MWqxJI1O M{HtflIhcHK| MoLwR5l1d3C{b4TlZ5Rqd25iYXfhbY5{fCCSUT3pcoR2[2WmIHPlcIwh\GWjdHigbY4hcHWvYX6gV2suVi2ERTiyLU1OOTdiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZ4VtdCC4aXHibYxqfHliYYSgNUBuVSCycnX0doVifGWmIH\vdkAzKGi{czDmc4xtd3enZDDifUAyKG2PIGDRJIFl\Gm2aX;uJI1m[XO3cnXkJIFnfGW{IEK0JIhzeyCkeTDNWHQh[XO|YYm= MV68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDJ6NUmxOUc,Ojh{OEW5NVU9N2F-
SK-N-BE(2)-M17 MnfRR5l1d3C{b4TlZ5Rqd25iYYPzZZk> MnfwNUBuVQ>? NFiydIUzKGi{cx?= NWriPXBxS3m2b4Dyc5Rm[3Srb36gZYdicW6|dDDINm8zNWmwZIXj[YQh[2WubDDk[YF1cCCrbjDoeY1idiCVSz3OMWJGMDJrLV2xO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiClZXzsJJZq[WKrbHn0fUBifCBzIH3NJJBz\XS{ZXH0[YQh\m:{IEKgbJJ{KG[xbHzve4VlKGK7IEGgcW0hUDKRMjDh[IRqfGmxbjDt[YF{fXKnZDDh[pRmeiB{NDDodpMh[nliTWTUJIF{e2G7 NHe4d|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEK4OVkyPSd-MkiyPFU6OTV:L3G+
DAOY M4TnZZFJXFNiYYPzZZk> MofBdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKESDT2mgZ4VtdHN? NIDXNIs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
BT-37 NHniNXFyUFSVIHHzd4F6 NICwPYNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStN|ch[2WubIO= M4foTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH MYrxTHRUKGG|c3H5 NEnYb2pyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1UUCClZXzsdy=> M{\Rb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-12 NECxZZJyUFSVIHHzd4F6 NInreGNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
OHS-50 MkHTdWhVWyCjc4PhfS=> NXjFTnN2eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF;IV{02OCClZXzsdy=> MlmxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 100 mg/mL (152.25 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 656.79
Formula

C26H52N6O11S

CAS No. 138-14-7
Storage powder
in solvent
Synonyms Desferrioxamine B, DFOM, NSC 644468
Smiles CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Deferoxamine mesylate (Ba 33112) | Deferoxamine mesylate (Ba 33112) supplier | purchase Deferoxamine mesylate (Ba 33112) | Deferoxamine mesylate (Ba 33112) cost | Deferoxamine mesylate (Ba 33112) manufacturer | order Deferoxamine mesylate (Ba 33112) | Deferoxamine mesylate (Ba 33112) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID